Our journey of innovation began in 2010. At globally renowned medical institution, our founding team developed a revolutionary preclinical CT image-guided precision radiation system, pioneering the innovative application of image-guided technology in cutting-edge research fields. In 2015, we conquered in vivo 3D optical molecular imaging technology, and developed the state-of-the-art ''3D molecular imaging + CT'' multimodal imaging system, providing a unique 3D quantitative research tool for the study of animal disease models.
In 2017, our team achieved another technological breakthrough by successfully upgrading the 3D multimodal image-guided technology into a precision radiotherapy system, further solidifying our leading position in the preclinical radiotherapy field. Subsequently, Raycision Medical Technology was established, initiating the process of technological industrialization. We have since launched a series of products, including high-resolution Micro-CT, three-dimensional optical imaging, and multimodal precision radiation systems, continuously serving global customers with pioneering original technology.
As our business rapidly expands, we have established R&D centers in several key cities across the country, gradually expanding our research team, business partners, and global branches. As a pioneer of original technology in the fields of biomedical imaging and radiotherapy, we are committed to empowering the scientific research community with the most advanced technology, becoming a steadfast supporter on the path of scientific innovation and exploration.
Vision: Dedication to state-of-the-art biomedical imaging and radiation solutions
Values: Innovation, Collaboration, Commitment
English
